Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.15420/AER.2016.10.2 http://scihub22266oqcxt.onion/10.15420/AER.2016.10.2 C5016598!5016598!27617090     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Arrhythm+Electrophysiol+Rev 2016 ; 5 (2): 117-21 Nephropedia Template TP {{tp|p=27617090|t=2016. Antiarrhythmic Drug Therapy to Avoid Implantable Cardioverter Defibrillator Shocks |pdf=|usr=}}{{27617090}} gab.com Text Antiarrhythmic Drug Therapy to Avoid Implantable Cardioverter Defibrillator Shocks JO: Arrhythm Electrophysiol Rev http://www.kidney.de/pget.php?&tw=1&pmid=27617090 #FOAvip Implantable cardioverter defibrillators (ICDs) are effective in the prevention of arrhythmic sudden cardiac death. Many patients receiving an ICD are affected by heart failure and are at risk of ventricular arrhythmias, which may lead to appropriate shocks. On the other hand, in this population the incidence of atrial fibrillation, giving rise to inappropriate ICD shocks, is high. Accordingly, ICD discharges occur frequently and many patients with an ICD will need concomitant antiarrhythmic drug therapy to avoid or reduce the frequency of shocks. Therapeutic agents such as ?-blockers, class I or class III antiarrhythmic drugs effectively suppress arrhythmias, but may have side-effects. Some drugs could eventually influence the function of ICDs by altering defibrillation or pacing threshold. Few prospective randomised trials are available, but current data suggest that amiodarone is most effective for prevention of appropriate or inappropriate ICD shocks. This review article summarises current knowledge regarding the antiarrhythmic management of patients with ICDs. Twit Text FOAVip Antiarrhythmic Drug Therapy to Avoid Implantable Cardioverter Defibrillator Shocks ????Arrhythm Electrophysiol Rev http://www.kidney.de/pget.php?&tw=1&pmid=27617090 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=27617090 #FOAvip English Wikipedia <ref>{{Cite pmid|27617090}}</ref> Antiarrhythmic Drug Therapy to Avoid Implantable Cardioverter Defibrillator Shocks #MMPMID27617090 Abboud J; R Ehrlich J Arrhythm Electrophysiol Rev 2016[Aug]; 5 (2): 117-21 PMID27617090show ga Implantable cardioverter defibrillators (ICDs) are effective in the prevention of arrhythmic sudden cardiac death. Many patients receiving an ICD are affected by heart failure and are at risk of ventricular arrhythmias, which may lead to appropriate shocks. On the other hand, in this population the incidence of atrial fibrillation, giving rise to inappropriate ICD shocks, is high. Accordingly, ICD discharges occur frequently and many patients with an ICD will need concomitant antiarrhythmic drug therapy to avoid or reduce the frequency of shocks. Therapeutic agents such as ?-blockers, class I or class III antiarrhythmic drugs effectively suppress arrhythmias, but may have side-effects. Some drugs could eventually influence the function of ICDs by altering defibrillation or pacing threshold. Few prospective randomised trials are available, but current data suggest that amiodarone is most effective for prevention of appropriate or inappropriate ICD shocks. This review article summarises current knowledge regarding the antiarrhythmic management of patients with ICDs. äAntiarrhythmic Drug Therapy to Avoid Implantable Cardioverter Defibril(epmc).pdf DeepDyve Pubget Overpricing